Vertex Inc. logo

Vertex Inc. (VERX)

Market Closed
17 Jul, 20:00
NASDAQ (NMS) NASDAQ (NMS)
$
12. 80
-0.36
-2.7356%
$
2.06B Market Cap
- P/E Ratio
- Div Yield
836,900 Volume
0.38 Eps
$ 13.16
Previous Close
Add Transaction
Day Range
12.77 13.31
Year Range
10.21 36.75
Want to track VERX and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Summary

VERX closed yesterday lower at $12.8, a decrease of -2.7356% from Thursday's close, completing a monthly decrease of -7.1118% or -$0.98. Over the past 12 months, VERX stock lost -35.968%.
VERX is not paying dividends to its shareholders.
The last earnings report, released on May 05, 2026, exceeded the consensus estimates by 0%. On average, the company has fell short of earnings expectations by -0.1133%, based on the last three reports.
The stock of the company had never split.
The company's stock is traded on 7 different exchanges and in various currencies, with the primary listing on NASDAQ (NMS) (USD).

VERX Chart

People also search for

Applied Optoelectronics, Inc.
$ 102.41
+2.1648%
TTD
The Trade Desk, Inc. Class A
$ 18.59
-2.772%
Camtek Ltd.
$ 146.15
-1.1966%
Acm Research Inc.
$ 83.92
-0.2022%
GDS
GDS Holdings Ltd. - ADR
$ 31.16
-4.855%
Vertex Pharmaceuticals Bets $10 Billion on Crinetics to Build Endocrinology Powerhouse

Vertex Pharmaceuticals Bets $10 Billion on Crinetics to Build Endocrinology Powerhouse

Vertex Pharmaceuticals NASDAQ: VRTX said it has entered into a definitive agreement to acquire Crinetics Pharmaceuticals for $85 per share in cash, a transaction Vertex executives described as a strategic expansion into specialty endocrinology.

Marketbeat | 1 week ago
Vertex's Crinetics Deal Balances Growth with Integration Risk

Vertex's Crinetics Deal Balances Growth with Integration Risk

Vertex Pharmaceuticals NASDAQ: VRTX recently announced its plans to acquire Crinetics Pharmaceuticals NASDAQ: CRNX for $10 billion. The deal, which has already been approved by the board of directors of both companies, is expected to close in the third quarter of 2026.

Marketbeat | 1 week ago
Crinetics shares surge after Vertex agrees to $10B cash buyout

Crinetics shares surge after Vertex agrees to $10B cash buyout

Crinetics Pharmaceuticals shares surged after Vertex Pharmaceuticals announced an agreement to acquire the endocrinology-focused biotech company in a deal valued at approximately $10 billion. The all-cash transaction values Crinetics at $85 per share and is expected to close during the current quarter, subject to customary conditions.

Invezz | 1 week ago

Vertex Inc. Investors

Name Quantity Cost Value Profit ($) Gain (%)
CE
Curtis Ellergodt Rothschild Investment LLC
97 $1,937 $1,240.63 -$696.37 -35.95%
SN
Stephanie Nee HARBOR CAPITAL ADVISORS Inc.
20,769 $246,943.41 $266,362.42 $19,419.01 7.86%
BG
Bart Gancher Intech Investment Management LLC
19,645 $735,290.74 $253,098.32 -$482,192.42 -65.58%
YA
Yinka Akinsola Blue Trust Inc.
38 $1,342.73 $485.39 -$857.34 -63.85%
Jeff Ameen
Jeff Ameen Spire Wealth Management
330 $12,708.3 $4,204.2 -$8,504.1 -66.92%

Vertex Inc. (VERX) FAQ

What is the stock price today?

The current price is $12.80.

On which exchange is it traded?

Vertex Inc. is listed on NASDAQ (NMS).

What is its stock symbol?

The ticker symbol is VERX.

Does it pay dividends? What is the current yield?

It does not pay dividends to its shareholders.

What is its market cap?

As of today, the market cap is 2.06B.

Has Vertex Inc. ever had a stock split?

No, there has never been a stock split.

Vertex Inc. Profile

Software Industry
Information Technology Sector
Christopher David Young CEO
NASDAQ (NMS) Exchange
92538J106 CUSIP
US Country
2,100 Employees
- Last Dividend
- Last Split
29 Jul 2020 IPO Date

Overview

Vertex, Inc., established in 1978 and based in King of Prussia, Pennsylvania, operates internationally, offering cutting-edge tax technology solutions tailored for the retail trade, wholesale trade, and manufacturing industries. The company specializes in helping enterprises navigate the complex landscape of tax determination, compliance, reporting, and data management through a suite of products and services delivered both as traditional software licenses and modern Software as a Service (SaaS) subscriptions. With a focus on innovation, Vertex, Inc. leverages its extensive experience and industry-specific insights to provide comprehensive tax technology solutions designed to meet the evolving needs of its global clientele.

Products and Services

  • Tax Determination - Vertex provides advanced solutions for accurate tax determination, ensuring compliance with local, state, and international tax regulations.
  • Compliance and Reporting - This service encompasses workflow management tools, role-based security, and event logging to streamline tax compliance and reporting processes.
  • Tax Data Management - Aims to efficiently manage and organize tax-related data, allowing for enhanced accuracy and accessibility.
  • Document Management - Offers solutions for the secure storage, retrieval, and management of tax documents, facilitating easier audit and compliance.
  • Analytics and Insights - Provides analytical tools and insights to help businesses make informed decisions based on their tax data.
  • Pre-built Integration - Includes mapping data fields, business logic, and configurations for seamless integration with existing business systems.
  • Industry-specific Solutions - Tailored solutions designed to meet the unique tax challenges of various industries.
  • Technology Specific Solutions - Includes offerings like chain flow accelerator and SAP-specific tools to enhance tax processing for businesses utilizing specific technologies.
  • Implementation Services - Vertex offers configuration, data migration, implementation support, and training to ensure successful software deployment.
  • Managed Services - This comprehensive service includes tax return preparation, filing, tax payment, and notice management, allowing businesses to outsource their tax management.

Contact Information

Address: 2301 Renaissance Boulevard
Phone: 800 355 3500